ARTICLE AD BOX
A Mayo Clinic-led study reports that postmenopausal women using menopausal hormone therapy experienced significantly greater weight loss when taking tirzepatide, a Food and Drug Administration-approved medication for overweight and obesity. On average, these women lost about 35% more weight compared to those using tirzepatide alone. The results, published in The Lancet Obstetrics, Gynaecology, & Women's Health, point to new possibilities for treating obesity and relate...

1 hour ago
6








English (US) ·